Citable filing context
NDSN's research view summarizes recent SEC filing context, starting with earnings from Aug 19, 2026.
| Filed | Item | Context |
|---|---|---|
| Aug 19, 2026 | earnings | Nordson Corporation reported record Q3 fiscal 2026 sales of $818 million and increased its full-year guidance. |
| Jun 3, 2026 | debt_offering | Nordson Corporation established a new commercial paper program with a maximum aggregate amount of $1.2 billion. |
| May 20, 2026 | earnings | Nordson reported record Q2 2026 sales of $741 million and increased its full-year guidance. |
| Aug 19, 2026 | Guidance: adjusted_earnings_per_diluted_share | 11.80 to 12.00 |
| Aug 19, 2026 | Guidance: sales | 3035.00 to 3075.00 |
| May 20, 2026 | Guidance: adjusted_eps | 11.30 to 11.80 |
| Aug 20, 2026 | mda_quarterly | Nordson Corporation generated third-quarter fiscal 2026 sales of $817.7 million, a 10.3% increase year-over-year, driven by 11.7% organic sales growth. Net income for the quarter rose 21.5% to $152.8 million, or $2.73 per diluted share. Operating performance was anchored by Advanced Technology Solutions, where organic sales jumped 30.9% on robust demand for electronics dispense and test and inspection product lines, driving a 560 basis point expansion in segment EBITDA margin. Medical and Fluid Solutions posted 10.6% organic growth, led by engineered fluid solutions and medical components, while Industrial Precision Solutions recorded 3.3% organic growth across packaging, industrial coatings, polymer processing, and nonwovens. Regionally, Asia Pacific led organic growth at 24.1%. For the first nine months, operating cash flow reached $570.5 million. Nordson deployed capital toward $258 million in net debt reduction, $159 million in share repurchases, $137 million in dividends, and the March 2026 acquisition of CapstanAG to expand precision agriculture capabilities. Results reflect a $24.0 million nine-month pension settlement charge and a $14.9 million third-quarter unrealized loss on a minority investment, partially offset by lower interest expense from debt paydowns. Liquidity remains strong, supported by $113.4 million in cash and $1.14 billion in available capacity under a restructured $1.2 billion revolving credit facility and commercial paper program. |
| May 21, 2026 | mda_quarterly | Nordson Corporation reported six-month sales of $1.41 billion, an 8.6% increase over the prior year, with net income rising 21.1% to $250.7 million. Growth was led by the Advanced Technology Solutions segment, where sales grew 15.7% driven by exceptional demand for electronic dispense systems. The Industrial Precision Solutions segment saw a 9.4% increase, supported by industrial coating, polymer processing, and precision agriculture. Medical and Fluid Solutions grew 2.4%, primarily through engineered fluid solutions. Geographically, the Asia Pacific region exhibited the strongest growth at 16.4%. Operating profit increased 17.4% to $363.6 million, though results were tempered by a $24.0 million loss from a U.S. pension plan settlement involving a group annuity contract with RGA. The company maintains strong liquidity with a $1.2 billion revolving credit facility and utilized operating cash to repay $107 million in debt, repurchase $129 million in common shares, and pay $92 million in dividends. Key risks to future cash flow and liquidity include international conflicts, shifting trade policies, and tariffs. |
Source: SEC EDGAR filing text and events; period Aug 19, 2026; filed Aug 19, 2026.
NDSN company research is free during early access. All you need is an account, with no card required. The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay open without one.
Continue research
Follow same-sector companies and source explainers connected to the research view.
A factual guide to SEC Form 8-K current reports and the material company events they can disclose between quarterly filings.
A factual guide to quarterly SEC Form 10-Q reports, how they differ from annual 10-K filings, and what readers can inspect first.
A factual guide to Form S-1 registration statements and the disclosures companies provide before a public offering.
A factual guide to the core 10-K sections investors use for company context: business description, risk factors, MD&A, financial statements, and segment disclosures.